Sign In
Buy FATE
$2.22
-0.350 (-13.62%)
At Close: Jun 03, 2026
2 Best Biotech Stocks to Buy in January
06:42am, Thursday, 28'th Jan 2021
These two companies are at the forefront of innovation during our golden age of biotech.
Time To Book Profit In Fate Therapeutics Stock After A 5x Rally?
10:00am, Friday, 22'nd Jan 2021
After a stellar 5x rise since the March 23 levels of last year, at the current price of around $114 per share we believe Fate Therapeutics stock, a biopharmaceuticals company focused on oncology and i
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
02:22pm, Saturday, 16'th Jan 2021
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying c
SAN DIEGO, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the develop
Is the Options Market Predicting a Spike in Fate Therapeutics (FATE) Stock?
09:47am, Friday, 08'th Jan 2021
Investors need to pay close attention to Fate Therapeutics (FATE) stock based on the movements in the options market lately.
Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
12:30am, Wednesday, 06'th Jan 2021
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the developm
3 Biotech Stocks That Could Double Your Money in 2021
06:23am, Tuesday, 05'th Jan 2021
Clinical trial readouts this year could cause these closely watched biotech stocks to explode overnight.
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
04:01pm, Monday, 04'th Jan 2021
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the developm
Here's a Cancer-Killing Stock to Buy for 2021
07:18am, Wednesday, 30'th Dec 2020
"Natural killer" (or NK) cancer therapies are hot right now. Here are two stocks that are early leaders in the field -- one is a buy, and the other one is not.
5 Biotech Stocks That Have Gained More Than 200% in 2020
10:32am, Tuesday, 29'th Dec 2020
Some biotech stocks have risen more than 200% this year. Here we discuss five such stocks.
FATE Surges More Than 152% in Three Months: Here's Why?
11:17am, Monday, 28'th Dec 2020
FATE's recent positive pipeline updates have led to a significant upsurge in the stock price.
Here's Why Fate Therapeutics' Data Produced a 38% Jump in the Stock Price
09:21am, Wednesday, 23'rd Dec 2020
The biotech's natural killer cell therapies have real potential.
5 Biotech Stocks That More Than Doubled This Year
09:47am, Monday, 21'st Dec 2020
The biotech sector has been in focus through 2020 as companies like Moderna (MRNA) strive hard to develop a vaccine for COVID-19.
Fate Therapeutics Stock Price Increases 37.8%: Why It Happened
07:55am, Tuesday, 08'th Dec 2020
The stock price of Fate Therapeutics Inc (NASDAQ: FATE) has increased by 37.8% (from $60.79 on December 6 to $83.77 on December 7). This is why.
Why Fate Therapeutics Stock Is Skyrocketing Today
12:39pm, Monday, 07'th Dec 2020
The biotech reported great news on Friday and Saturday for two of its cancer immunotherapy candidates.
